PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Pergolide mesilate
Presentation Product Chemical substance Chapter Items dispensed
Celance 1mg tablets
0409010P0BBACAC
Celance Pergolide mesilate Central Nervous System No data available
Celance 250microgram tablets
0409010P0BBABAB
Celance Pergolide mesilate Central Nervous System No data available
Celance 50microgram tablets
0409010P0BBAAAA
Celance Pergolide mesilate Central Nervous System No data available
Celance tablets 14 day starter pack
0409010P0BBADAE
Celance Pergolide mesilate Central Nervous System No data available
Celance tablets 30 day starter pack
0409010P0BBAEAE
Celance Pergolide mesilate Central Nervous System No data available
Pergolide 1mg tablets
0409010P0AAACAC
Pergolide mesilate Pergolide mesilate Central Nervous System No data available
Pergolide 250microgram tab and Pergolide 50microgram tab
0409010P0AAAEAE
Pergolide mesilate Pergolide mesilate Central Nervous System No data available
Pergolide 250microgram tablets
0409010P0AAABAB
Pergolide mesilate Pergolide mesilate Central Nervous System No data available
Pergolide 50microgram tablets
0409010P0AAAAAA
Pergolide mesilate Pergolide mesilate Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.